Mucoadhesive nanopolymer - A novel drug carrier for topical ocular drug delivery

European Journal of Scientific Research

Volumn 46, Issue 3, 2010, Pages 401-409

  Sahoo, Soumendra ^a   Sahoo, Rashmirekha ^b   Nanda, Rajashree ^c   Tripathy, M K ^d   Nayak, P L ^c  

^a MELAKA MANIPAL MEDICAL COLLEGE   (India)

^b Faculty of Science and Technology   (Malaysia)

^c PLNayak Research Foundation   (India)

^d UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Drug delivery; Mucoadhesive; Nanoparticles; Ocular; Polysaccharides

Indexed keywords

EID: 79960108820     PISSN: 1450216X     EISSN: 1450202X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Haynes, R. J., P. J. Tighe, and H. S. Dua. 1999. Antimicrobial defensin peptides of the human ocular surface. Br. J. Ophthalmol. 83:737-741. (Pubitemid 29261667)
2. McClellan, K. A. 1997. Mucosal defense of the outer eye. Surv. Ophthalmol. 42:233-246.
3. S Mishima: Clinical pharmacokinetics of the eye. Invest. Ophthalmol. Vis. Sci. 21, 504-541 (1981).
4. Lang JC: Ocular drug delivery: conventional ocular formulations. Adv. Drug Delivery Revs.16, 39-43 (1995).
5. Hideya K, Yuichiro O: Ophthalmologica.215, 143-1457 (2001).
6. Saettone MF, Giannaccini B, Teneggi A, Savigni P, Tellini N: Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man, J. Pharm. Pharmacol. 34, 464-466 (1982). (Pubitemid 12082550)
7. Trueblood JH, Rossomondo RM, Carlton WH, Wilson LA: Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy, Arch. Ophthalmol. 93, 127-130 (1975).
8. Saettone MF, Giannaccini B, Ravecca S, La Marca F, Tota G: Polymer effects on ocular bioavailability - the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and rabbits, Int. J. Pharm. 20, 187-202 (1984). (Pubitemid 14091719)
9. Greaves JL, Wilson CG: Treatment of diseases of the eye with mucoadhesive delivery systems, Adv. Drug Deliv. Rev. 11, 349-383 (1993). (Pubitemid 23302852)
10. Saettone MF, Burgalassi S, Chetoni P: Ocular bioadhesive drug delivery systems, in: E. Mathiowitz, D.E. Chickering, C.-M. Lehr (Eds.), Bioadhesive Drug Delivery Systems.
11. A. Ludwig / Advanced Drug Delivery Reviews 57 (2005) 1595-1639 1629 Fundamentals, Novel Approaches and Development, Marcel Dekker, Inc., New York, 601-640 (1999).
12. Lee VHL, Robinson JR: Review: topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2, 67-108 (1986). (Pubitemid 17193813)
13. Saettone MF, Giannaccini B, Guiducci A, Marca F, Tota G. Polymer effects on ocular bioavailability: II. The influence of benzalkonium chloride on the mydriatic response of tropicamide in different polymeric vehicles, Int. J. Pharm. 25, 73-83 (1985). (Pubitemid 15052739)
14. Bravo O, Herrero V: Potential of dendrimers as drug carriers in ophthalmology, Ach. Soc. Esp. Oftal.82, 69-70 (2007).
15. Mainardes RM, Urban. MCC, Cinto PO, Khali NM, Chaud. MV, Evangelista. RC et al.,: Curr. Drug. Targets.6, 363 (2005).
16. Le Bourlais CA, Treupel-Acar L, Rhodes CT, Sado PA, Leverge R: New ophthalmic drug delivery systems, Drug Dev. Ind. Pharm. 21, 19-59 (1995).
17. Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R: Ophthalmic drug delivery systems - recent advances, Prog. Retin. Eye Res. 17, 33-58 (1998). (Pubitemid 28040752)
18. Klein HZ, Lugo Shields MB, Leon J, Duzman E: A dose-response study of Piloplex for duration of action, Am. J. Ophthalmol. 99, 23-26 (1985). (Pubitemid 15194734)
19. Inoue T, Chen G, Nakamae K, Hoffman AS: An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs, J. Control. Release 51, 221-229 (1998). (Pubitemid 28252874)
20. Kreuter J: Particulates (nanoparticles and microparticles), in: A.K. Mitra (Ed.), Ophthalmic Drug Delivery Systems, Marcel Deker, New York, 275-297 (1993).
21. Zimmer A, Kreuter J: Microspheres and nanoparticles used in ocular delivery systems, Adv. Drug Deliv. Rev. 16, 61-73 (1995).
22. Fresta M, Fontana G, Bucolo C, Cavallaro G, Giammona G, Puglisi G: Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2- cyanoacrylate nanospheres-encapsulated acyclovir, J. Pharm. Sci. 90, 288-297 (2001).
23. Pignatello R, Bucolo C, Puglisi G: Ocular tolerability of Eudragit RS 100R and RL 100R nanosuspensions as carriers for ophthalmic controlled drug delivery, J. Pharm. Sci. 91, 2636-2641 (2002). (Pubitemid 35379421)
24. Le Bourlais CA, Chevanne F, Turlin B, Acar L, Zia H, Sado PA, Needham TE, Leverge R: Effect of cyclosporine A formulations on bovine corneal absorption: ex vivo study, J. Microencapsul 14, 457-467 (1997). (Pubitemid 27313368)
25. Geroski DH, Edelhauser HF: Drug delivery for posterior segment eye disease. Investigative Ophthalmology and Visual Science 41, 961-4 (2000). (Pubitemid 30187528)
26. Pignatello R, Bucolo C, Puglisi G: Ocular tolerability of Eudragit RS 100R and RL 100R nanosuspensions as carriers for ophthalmic controlled drug delivery, J. Pharm. Sci. 91, 2636-2641 (2002). (Pubitemid 35379421)
27. Pignatello R., Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G, Eudragit RS: 100R nanosuspensions for ophthalmic controlled delivery of ibuprofen, Eur. J. Pharm. 16, 53-61 (2002). (Pubitemid 34756782)
28. Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G: Flurbiprofen- loaded acrylate polymer nanosuspensions for ophthalmic application, Biomaterials 23, 3247-3255 (2002). (Pubitemid 34522137)
29. Salamanaca. E.D, Diebold. Y, Calonge. M, Gracia. C, Callejo. S, Villa. A. et al, Invest. Ophthalmol. Visual. Sci.47, 1416 (2006).
30. Calvo P, Vila-Jato JL, Alonso MJ: Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers, Int. J. Pharm. 153, 41-50 (1997). (Pubitemid 27283332)
31. De Campos AM, Sanchez A, Gref R, Calvo P, Alonso MJ: The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa, Eur. J. Pharm. Sci. 20, 73-81 (2003). (Pubitemid 37103234)
32. De Campos AM, Sanchez A, Alonso M: Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporine A, Int. J. Pharm. 224, 159-168 (2001). (Pubitemid 32706495)
33. Kimura H, Ogura Y: Biodegradable polymers for ocular drug delivery, Ophthalmologica 215, 143-155 (2001). (Pubitemid 32525970)
34. Giannavola C, Bucolo C, Maltese A, Paolino D, Vandelli MA, Puglisi G, Lee VHL, Fresta M: Influence of preparations on acyclovir-loaded poly-d, l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability, Pharm. Res. 20, 584-590 (2003). (Pubitemid 36438901)
35. Kyyrönen K, Hume L, Benedetti L, Urtti A, Topp E, Stella V: Methyl prednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release, Int. J. Pharm. 80, 161-169 (1992).
36. Giunchedi P, Conte U, Chetoni P, Saettone MF: Pectine microspheres as ophthalmic carriers for piroxicam evaluation in vitro and in vivo in albino rabbits, Eur. J. Pharm. Sci.9, 1-7 (1999). (Pubitemid 29430186)
37. Burgalassi, S., L. Panichi, P. Chetoni, M. F. Saettone, and E. Boldrini. 1999. Development of simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 31:229-235. (Pubitemid 29219120)
38. Burgalassi, S., L. Raimondi, R. Pirisino, G. Banchelli, E. Boldrini, and M. F. Saettone. 2000. Effect of xyloglucan (tamarind seed polysaccharide) on conjunctiva cell adhesion to laminin and on corneal epithelium wound healing. Eur. J. Ophthalmol. 10:71-76. (Pubitemid 30191108)
39. Raimondi, L., G. Sgromo, R. Banchelli, I. Corti, R. Pirisino, and E. Boldrini. 2000. A new viscosity enhancer for ophthalmic preparations devoid of toxicity for human conjunctiva cells. J. Toxicol. Cut. Ocular Toxicol. 19:31-42. (Pubitemid 30123879)
40. Ghelardi, E., A. Tavanti, F. Celandroni, A. Lupetti, C. Blandizzi, E. Boldrini, M. Campa, and S. Senesi. 2000. Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits. J. Antimicrob. Chemother. 46:831-834.
41. J. Ceulemans, I. Vinckier, A. Ludwig. The use of xanthan gum in an ophthalmic liquid dosage form:rheological charecterisation of the interaction with mucin, J. Pharm. Sci. 91 (2002) 1117-1127 (Pubitemid 34640936)
42. A. ZIMMER, P. Maincent, P. Thouvenot, J. Kreuter, Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles. Int. J. Pharm. 110 (1994) 211-222 (Pubitemid 24274228)
43. A.K. Zimmer, P. Chetoni, M.F. Saettone, H. Zerbe, J. Kreuter, Evaluation of pilocarpine loaded albumin particles as controlled drug delivery systems for the eye:II. Co-administration with bioadhesive and viscous polymers, J. Control. Release 33(1995) 31-46
44. R. Cavalli, M.R. Gasco, P. Chetoni, S. Bugalaasi, M.F. Settone, Solid lipid nanoparticles(SLN) as ocular delivery system for Tobramycin, Int. J. Pharm. 238 (2002) 241-245 (Pubitemid 34457892)